Daré Bioscience(DARE) - 2021 Q1 - Quarterly Report
Daré Bioscience(DARE)2021-05-13 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-36395 20-4139823 (IRS Employer Identification No.) 3655 Nobel Drive, Suite 260 San Diego, CA (Address of Principal Executive Offices) ...